CME Group Names Kevin Wenta As Director, Strategy Execution

CME Group, the world's largest and most diverse derivatives exchange, today announced that it has named Kevin Wenta as Director, Strategy Execution. In this newly created position, Wenta, 45, will be responsible for working with the company's business units to identify, prioritize and track strategic initiatives to drive bottom line results. He will report to Jason Weller, Managing Director, Corporate Strategy.

Prior to joining CME Group, Wenta gained 20 years of experience in strategy, operational planning, sales and business development. He most recently served as Executive Vice President of Nanophase Technologies where he was responsible for transforming the company into a market driven organization. He also worked as a Partner with Accenture, General Manager of a $500 million global resin business and Director of Corporate Strategy for Eastman Chemical.

Wenta earned his bachelor's degree in chemical engineering from the University of Texas at Austin and his MBA in finance and economics from the University of Chicago Booth School of Business.